The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
ANXA5 (Annexin A5) is a Protein Coding gene. Diseases associated with ANXA5 include Pregnancy Loss, Recurrent 3 and Antiphospholipid Syndrome. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Regulation of CFTR activity (norm and CF). Gene Ontology (GO) annotations related to this gene include calcium ion binding and calcium-dependent phospholipid binding. An important paralog of this gene is ANXA4.
The global ANXA5 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for ANXA5, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ANXA5.
Report Scope
The ANXA5 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ANXA5 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ANXA5 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Genetex
Atlas Antibodies
Abbexa Ltd
BioLegend
USBiological
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Biopharmaceutical Companies
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ANXA5 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
ANXA5 (Annexin A5) is a Protein Coding gene. Diseases associated with ANXA5 include Pregnancy Loss, Recurrent 3 and Antiphospholipid Syndrome. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Regulation of CFTR activity (norm and CF). Gene Ontology (GO) annotations related to this gene include calcium ion binding and calcium-dependent phospholipid binding. An important paralog of this gene is ANXA4.
The global ANXA5 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for ANXA5, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ANXA5.
Report Scope
The ANXA5 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ANXA5 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ANXA5 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Genetex
Atlas Antibodies
Abbexa Ltd
BioLegend
USBiological
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Biopharmaceutical Companies
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ANXA5 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ANXA5 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 Market by Application
1.3.1 Global ANXA5 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Bioscience Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ANXA5 Market Perspective (2019-2030)
2.2 ANXA5 Growth Trends by Region
2.2.1 Global ANXA5 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ANXA5 Historic Market Size by Region (2019-2024)
2.2.3 ANXA5 Forecasted Market Size by Region (2025-2030)
2.3 ANXA5 Market Dynamics
2.3.1 ANXA5 Industry Trends
2.3.2 ANXA5 Market Drivers
2.3.3 ANXA5 Market Challenges
2.3.4 ANXA5 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ANXA5 Players by Revenue
3.1.1 Global Top ANXA5 Players by Revenue (2019-2024)
3.1.2 Global ANXA5 Revenue Market Share by Players (2019-2024)
3.2 Global ANXA5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ANXA5 Revenue
3.4 Global ANXA5 Market Concentration Ratio
3.4.1 Global ANXA5 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ANXA5 Revenue in 2023
3.5 ANXA5 Key Players Head office and Area Served
3.6 Key Players ANXA5 Product Solution and Service
3.7 Date of Enter into ANXA5 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ANXA5 Breakdown Data by Type
4.1 Global ANXA5 Historic Market Size by Type (2019-2024)
4.2 Global ANXA5 Forecasted Market Size by Type (2025-2030)
5 ANXA5 Breakdown Data by Application
5.1 Global ANXA5 Historic Market Size by Application (2019-2024)
5.2 Global ANXA5 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ANXA5 Market Size (2019-2030)
6.2 North America ANXA5 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ANXA5 Market Size by Country (2019-2024)
6.4 North America ANXA5 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ANXA5 Market Size (2019-2030)
7.2 Europe ANXA5 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ANXA5 Market Size by Country (2019-2024)
7.4 Europe ANXA5 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ANXA5 Market Size (2019-2030)
8.2 Asia-Pacific ANXA5 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ANXA5 Market Size by Region (2019-2024)
8.4 Asia-Pacific ANXA5 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ANXA5 Market Size (2019-2030)
9.2 Latin America ANXA5 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ANXA5 Market Size by Country (2019-2024)
9.4 Latin America ANXA5 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ANXA5 Market Size (2019-2030)
10.2 Middle East & Africa ANXA5 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ANXA5 Market Size by Country (2019-2024)
10.4 Middle East & Africa ANXA5 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad ANXA5 Introduction
11.1.4 Bio-Rad Revenue in ANXA5 Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific ANXA5 Introduction
11.2.4 Thermo Fisher Scientific Revenue in ANXA5 Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Detail
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems ANXA5 Introduction
11.3.4 R&D Systems Revenue in ANXA5 Business (2019-2024)
11.3.5 R&D Systems Recent Development
11.4 Lifespan Biosciences
11.4.1 Lifespan Biosciences Company Detail
11.4.2 Lifespan Biosciences Business Overview
11.4.3 Lifespan Biosciences ANXA5 Introduction
11.4.4 Lifespan Biosciences Revenue in ANXA5 Business (2019-2024)
11.4.5 Lifespan Biosciences Recent Development
11.5 Genetex
11.5.1 Genetex Company Detail
11.5.2 Genetex Business Overview
11.5.3 Genetex ANXA5 Introduction
11.5.4 Genetex Revenue in ANXA5 Business (2019-2024)
11.5.5 Genetex Recent Development
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Company Detail
11.6.2 Atlas Antibodies Business Overview
11.6.3 Atlas Antibodies ANXA5 Introduction
11.6.4 Atlas Antibodies Revenue in ANXA5 Business (2019-2024)
11.6.5 Atlas Antibodies Recent Development
11.7 Abbexa Ltd
11.7.1 Abbexa Ltd Company Detail
11.7.2 Abbexa Ltd Business Overview
11.7.3 Abbexa Ltd ANXA5 Introduction
11.7.4 Abbexa Ltd Revenue in ANXA5 Business (2019-2024)
11.7.5 Abbexa Ltd Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Detail
11.8.2 BioLegend Business Overview
11.8.3 BioLegend ANXA5 Introduction
11.8.4 BioLegend Revenue in ANXA5 Business (2019-2024)
11.8.5 BioLegend Recent Development
11.9 USBiological
11.9.1 USBiological Company Detail
11.9.2 USBiological Business Overview
11.9.3 USBiological ANXA5 Introduction
11.9.4 USBiological Revenue in ANXA5 Business (2019-2024)
11.9.5 USBiological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
